Sleep and Motor Learning in Stroke
Launched by UNIVERSITY OF OXFORD · Feb 17, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Sleep and Motor Learning in Stroke," is studying how sleep disruption after a stroke may affect a person's ability to move and recover. Specifically, the researchers want to see if how well someone sleeps during the early weeks after a stroke influences their recovery in motor skills, like using their arm. They will also look at whether changes in behavior while sleeping play a role in this process.
To participate in this study, individuals must be at least 18 years old and have experienced a stroke that affects their upper limb within the past week. They should be able to give consent to join the study or have a family member or friend provide advice if they are unable. If someone has another neurological condition, such as Parkinson's disease or Multiple Sclerosis, they won't be eligible. Participants will have the opportunity to help researchers understand the connection between sleep and recovery, which could lead to improved treatments for stroke patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participant is willing and able to give informed consent for participation in the study OR a positive opinion from a consultee is provided by a family member or carer (relative or friend) willing to provide personal consultee (PC) advice
- • Aged 18 years or above
- • Within 1 month of onset of stroke affecting the upper limb as confirmed by clinical diagnosis
- Exclusion Criteria:
- • Other neurological condition affecting movement (such as Parkinson's disease, Multiple Sclerosis)
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oxford, , United Kingdom
Patients applied
Trial Officials
Heidi Johansen-Berg, Professor
Principal Investigator
University of Oxford
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials